Wherein r1 represents a five-membered aromatic heterocycle selected from a n- or a c-linked mono- or di-substituted pyrazole, an n- or a c-linked optionally mono- or di-substituted triazole or an n- or a c-linked optionally mono- or di-substituted imidazole, which five-membered aromatic heterocycle may be substituted by one or two of the groups selected a methyl group, an ethyl group, ...

A catalyst for converting dimethyl ether into light olefins, including ethylene and propylene. The catalyst comprises a mixture of two zeolites, zsm-5 and zsm-35, intimately mixed and kept in close proximity in a porous extruded binder system. The resulting combination of zeolites demonstrates a synergistic effect with respect to the conversion of the dimethyl ether and has improved resistance to ...

This pharmaceutical composition contains a hydroxamic acid derivative, or a salt thereof, and a solubilizer, said hydroxamic acid derivative being selected from among (2s)-2-((4-((4-((1s)-1,2-dihydroxyethyl)phenyl)ethynyl)benzoyl)(methyl)amino)-n-hydroxy-n′,2-dimethylmalonamide, (2s)-2-((4-((4-((1r)-1,2-dihydroxyethyl)phenyl)ethynyl)benzoyl)(methyl)amino)-n-hydroxy-n′,2-dimethylmalonamide, and (2s)—n-hydroxy-2-((4...

A thermal insulator composition and methods of manufacturing made from an admixture of a molding compound, a fire suppressant, and a bonding agent. Water can be added to the admixture to develop the insulator into different phases such as liquid and semi-liquid. The molding compound may be a co-polymer such as an acrylate, polyethylmethacrylate, benzoyl peroxide, titanium dioxide, and one ...

A method of producing a product, for example a stretch blow moulded container having a metallic or pearlescent appearance, comprises selecting a mass, for example a container preform, comprising a thermoplastic polymer which incorporates a carrier polymer and stretching the thermoplastic polymer during production of said product, for example from said mass. Said carrier polymer is suitably polydimethylsiloxane and the ...

The present invention relates to the pharmaceutical field, provides novel crystalline forms, solvates and the crystalline forms thereof of compound 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-n,2-dimethylbenzofuran-3-carboxamide, pharmaceutical compositions, as well as the methods of preparation and the use thereof.

The present invention provides a system and method of storing hydrogen (h2) and releasing it on demand, comprising and making use of diaminoalkanes and alcohols, or aminoalcohols as liquid-organic hydrogen carrier systems (lohc). 2-amino-ethanol (ae) or its n-methyl derivative 2-(methylamino)ethanol undergo catalytic dehydrogenation to form a cyclic dipeptide (glycine anhydride—ga) or its n,n-dimethyl derivative (n,...

A separation module that includes a porous membrane, where the porous membrane includes a poly(phenylene ether) copolymer containing 10 to 40 mole percent repeat units derived from 2-methyl-6-phenylphenol and 60 to 90 mole percent repeat units derived from 2,6-dimethylphenol; and a block copolymer containing backbone or pendant blocks of poly(c2-4 alkylene oxide). The separation module can be used in devices ...

A porous membrane is made from a poly(phenylene ether) copolymer containing 10 to 40 mole percent repeat units derived from 2-methyl-6-phenylphenol and 60 to 90 mole percent repeat units derived from 2,6-dimethylphenol; and a block copolymer containing backbone or pendant blocks of poly(c2-4 alkylene oxide). The porous membrane is made by dissolving the poly(phenylene ether) copolymer in a water-miscible ...

A cleaning fluid for cleaning a site to which ink adheres in an inkjet printer which ejects aqueous inkjet ink containing a pigment and alkali-soluble resin having an acid group in a molecule, wherein the cleaning fluid contains an amphoteric surfactant, a basic compound, and water, a ph range of the cleaning fluid is from 9 to 12, the amphoteric surfactant is ...

A thermoplastic polyurethane resin composition having enhanced texture and durability is capable of ensuring excellent appearance quality by applying polyester polyol including, polytetramethylene ether glycol and polydimethylsiloxane diol to an existing thermoplastic polyurethane resin composition, having excellent mechanical properties and long-term durability, such as anti-scratch and abrasion resistance, while largely enhancing texture quality, largely reducing producing costs by replacing a ...

Methods of synthesizing fluorosilanes containing cyano-substituted alkyl groups are provided. For example, 3-cyano-propyldimethylfluorosilane may be produced by reacting tetramethyldisiloxane and boron trifluoride to obtain fluorodimethylsilane and then reacting the fluorodimethylsilane with allyl cyanide, in the presence of a hydrosilylation catalyst

The present invention provides a process for preparation of {(2e,4e,6e,8e)-9-(4-methoxy-2,3,6-trimethyl)phenyl-3,7-dimethyl-nona-2,4,6,8}tetraenoate, an acitretin intermediate of formula (vi) with trans isomer≧97%, comprising of reacting 3-formyl-crotonic acid butyl ester of formula (v), substantially free of impurities, with 5-(4-methoxy-2,3,6-trimethylphenyl)-3-methyl-penta-2,4-diene-1-triphenyl phosphonium bromide of formula (iv) and isolating resultant ...

An ink set includes an ink a including water, a first organic solvent, and a first pigment and an ink b including water, a second organic solvent, a second pigment, and a urethane resin particle. The first organic solvent includes at least one of n,n-dimethyl-β-buthoxy propionamide, n,n-dimethyl-β-methoxy propionamide, and 3-ethyl-3-hydroxymethyl oxetane ...

This invention provides a method of synthesizing new active compounds for pharmaceutical uses including cancer treatment, wherein the cancers comprise breast, leukocytic, liver, ovarian, bladder, prostatic, skin, bone, brain, leukemia, lung, colon, cns, melanoma, renal, cervical, esophageal, testicular, spleenic, kidney, lymphatic, pancreatic, stomach and thyroid cancers. This invention is an anti-adhesion therapy which uses the compound as a mediator or ...

Provided herein are methods of producing dialkylfurans, such as 2,5-dimethylfuran, and other alkyl furans, such as 2-methylfuran. For example, 2,5-dimethylfuran may be produced by hydrogenation of (5-methylfuran-2-yl) methanol or 2-(chloromethyl)-5-methylfuran in the presence of a solid supported metal catalyst having an excess of either basic or acidic sites (as determined by chemisorption of co2 or nh3). ...

Provided is a preparation method for revaprazan hydrochloride, the method comprising: (1) the preparation of 4-hydroxyl-2-(4-fluoroaniline)-5,6-dimethylpyrimidine; (2) the preparation of 4-chloro-2-(4-fluoroaniline)-5,6-dimethylpyrimidine; (3) the preparation of revaprazan hydrochloride. The method has advantages such as simple operations, high product purity, good yield and suitability for industrial production.

A method and a device system for producing dimethyl oxalate through high-pressure carbonylation of industrial synthesis gases and producing ethylene glycol through dimethyl oxalate hydrogenation. The method comprises the following steps: adopting industrial no, o2 and methanol as raw materials to perform an esterification reaction to produce methyl nitrite, then adopting industrial co and methyl nitrite to perform a carbonylation ...

Provided herein are compositions, systems, and methods for treating a disease, such as kidney and/or cardiovascular disease, with an agent that reduces the production of trimethylamine (tma) or trimethylamine-n-oxide (tmao) in a subject. In certain embodiments, the agent is: i) 3,3-dimethyl-1-butanol (dmb) or a dmb derivative or related compound, ii) acetylsalicylic acid or derivative thereof (e. G., with ...

Wherein ha is naphthalene-1,5-disulfonic acid, naphthalene-2-sulfonic acid, oxalic acid, benzenesulfonic acid, or sulfuric acid, or hydrates thereof, and crystalline forms thereof characterized by the powder x-ray diffraction diagram and the 13c cp/mas nmr solid state spectrum. Also described are compositions, methods of use and preparation thereof.

A personal care conditioning and/or styling composition for a keratin substrate comprising: (a) at least one conditioning and/or styling ter/tetra polymer obtained by polymerizing: (i) about 50 wt. % to 97 wt. % of at least one cationic or pseudo-cationic monomer selected from the group consisting of diallyl dimethyl ammonium chloride (dadmac), hydroxyethyl-pyrrolidone-methacrylate (mo6), and/or vinylpyrrolidone (vp); (ii) about 1 wt. % ...